Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3701-3710 of 4090 results

Catalogue Number:

PX-TA1551

Category:

G

Proteo Genix logo

Pozelimab Biosimilar – Anti-C5 mAb – Research Grade

Target: C5
Target Alias Name: Pozelimab /REGN-3918/C5/anti-C5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2073

Category:

G

Proteo Genix logo

Pradusinstobart Biosimilar – Anti-PD1 mAb – Research Grade

Target: PD1
Target Alias Name: anti-PD1/ Programmed cell death protein 1/ Protein PD-1/ hPD-1/ PDCD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2084

Category:

G

Proteo Genix logo

Prafnosbart Biosimilar – Anti-SKR1 mAb – Research Grade

Target: SKR1
Target Alias Name: anti-SKR1/ Activin receptor type-1/ Activin receptor-like kinase 2/ TSR-I/ ACVRLK2/ ACTR-I/ ALK-2/ Serine/threonine-protein kinase receptor R1/ TGF-B superfamily receptor type I/ ACVR1/ Activin receptor type I
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1602

Category:

G

Proteo Genix logo

Praluzatamab Biosimilar – Anti-ALCAM/ CD166 mAb – Research Grade

Target: ALCAM/ CD166
Target Alias Name: Praluzatamab /CX-2009/ALCAM/ CD166/anti-ALCAM/ CD166
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1491

Category:

G

Proteo Genix logo

Prasinezumab Biosimilar – Anti-SNCA mAb – Research Grade

Target: SNCA
Target Alias Name: Prasinezumab/PRX002/RG-7935/SNCA/anti-SNCA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1417

Category:

G

Proteo Genix logo

Prezalumab Biosimilar – Anti-ICOSLG/ B7-H2/ B7RP-1/ CD275 mAb – Research Grade

Target: ICOSLG/ B7-H2/ B7RP-1/ CD275
Target Alias Name: Prezalumab/AMG 557/MEDI-5872/ICOSLG/ B7-H2/ B7RP-1/ CD275/anti-ICOSLG/ B7-H2/ B7RP-1/ CD275
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1116

Category:

G

Proteo Genix logo

Priliximab Biosimilar – Anti-CD4 mAb – Research Grade

Target: CD4
Target Alias Name: Priliximab/cm-MT412/CD4/anti-CD4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1318

Category:

G

Proteo Genix logo

Pritoxaximab Biosimilar – Anti-shiga toxin type 1 B subunit mAb – Research Grade

Target: shiga toxin type 1 B subunit
Target Alias Name: Pritoxaximab/Shigamabs-(drug name for the combination of pritoxaximab and setoxaximab)/caStx1/shiga toxin type 1 B subunit/anti-shiga toxin type 1 B subunit
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1193

Category:

G

Proteo Genix logo

Pritumumab Biosimilar – Anti-VIM mAb – Research Grade

Target: VIM
Target Alias Name: Pritumumab/CLN G11/VIM /anti-VIM
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1533

Category:

G

Proteo Genix logo

Prolgolimab Biosimilar – Anti-PDCD1/ PD1/ CD279 mAb – Research Grade

Target: PDCD1/ PD1/ CD279
Target Alias Name: Prolgolimab/BCD-100/PDCD1/ PD1/ CD279/anti-PDCD1/ PD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo